Literature DB >> 25834332

Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer.

Devendra Desai1, Sudeep Shah1, Abhijit Deshmukh1, Philip Abraham1, Anand Joshi1, Tarun Gupta1, Ramesh Deshpande1, Varun Khandagale1, Siji George1.   

Abstract

AIM: To determine the incidence and risk factors for colorectal cancer (CRC) in patients with ulcerative colitis from a low prevalence region for CRC.
METHODS: Our prospective database yielded a cohort of 430 patients [age: 44 ± 14.6 years; 248 men (57.7%)] with ulcerative colitis (median disease duration 6, range: 1-39 years) for analysis. Of these, 131 (30.5%) had left-sided colitis and 159 (37%) extensive colitis. Patients with histologically confirmed CRC within the segment with colitis were compared with those without CRC, to determine the risk factors for the development of CRC.
RESULTS: Twelve patients (2.8%) developed CRC. The overall incidence density was 3.56/1000 patient-years of disease - 3/1000 in the first 10 years, 3.3/1000 at 10 to 20 years, and 7/1000 at > 20 years. Three of our 12 patients developed CRC within 8 years of disease onset. On univariate analysis, extensive colitis, longer duration of disease, and poor control of disease were associated with development of CRC. On multivariate analysis, duration of disease and extent of colitis remained significant.
CONCLUSION: CRC occurred in 2.8% of patients with ulcerative colitis in our population - an incidence density similar to that in Western countries in spite of a low overall prevalence of colon cancer in our population. The risk increased with extent and duration of disease.

Entities:  

Keywords:  Colon cancer; Dysplasia; Epidemiology; Inflammatory bowel disease; Malignancy

Mesh:

Year:  2015        PMID: 25834332      PMCID: PMC4375589          DOI: 10.3748/wjg.v21.i12.3644

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study.

Authors:  Wei Gong; Nonghua Lv; Bangmao Wang; Ye Chen; Yinglong Huang; Wenshen Pan; Bo Jiang
Journal:  Dig Dis Sci       Date:  2011-09-22       Impact factor: 3.199

Review 2.  Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).

Authors:  Stuart R Cairns; John H Scholefield; Robert J Steele; Malcolm G Dunlop; Huw J W Thomas; Gareth D Evans; Jayne A Eaden; Matthew D Rutter; Wendy P Atkin; Brian P Saunders; Anneke Lucassen; Paul Jenkins; Peter D Fairclough; Christopher R J Woodhouse
Journal:  Gut       Date:  2010-05       Impact factor: 23.059

3.  Colorectal cancer in India: controversies, enigmas and primary prevention.

Authors:  K M Mohandas
Journal:  Indian J Gastroenterol       Date:  2011-01-11

4.  Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States.

Authors:  Yize R Wang; John R Cangemi; Edward V Loftus; Michael F Picco
Journal:  Am J Gastroenterol       Date:  2013-01-08       Impact factor: 10.864

5.  Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010.

Authors:  Lisa J Herrinton; Liyan Liu; Theodore R Levin; James E Allison; James D Lewis; Fernando Velayos
Journal:  Gastroenterology       Date:  2012-05-15       Impact factor: 22.682

6.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

Review 7.  The Asia-Pacific consensus on ulcerative colitis.

Authors:  Choon Jin Ooi; Kwong Ming Fock; Govind K Makharia; Khean Lee Goh; Khoon Lin Ling; Ida Hilmi; Wee Chian Lim; Thia Kelvin; Peter R Gibson; Richard B Gearry; Qin Ouyang; Jose Sollano; Sathaporn Manatsathit; Rungsun Rerknimitr; Shu-Chen Wei; Wai Keung Leung; H Janaka de Silva; Rupert Wl Leong
Journal:  J Gastroenterol Hepatol       Date:  2010-03       Impact factor: 4.029

8.  Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.

Authors:  Tine Jess; Jacob Simonsen; Kristian Tore Jørgensen; Bo Vestergaard Pedersen; Nete Munk Nielsen; Morten Frisch
Journal:  Gastroenterology       Date:  2012-04-19       Impact factor: 22.682

9.  Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.

Authors:  Maurice W M D Lutgens; Martijn G H van Oijen; Geert J M G van der Heijden; Frank P Vleggaar; Peter D Siersema; Bas Oldenburg
Journal:  Inflamm Bowel Dis       Date:  2013 Mar-Apr       Impact factor: 5.325

10.  Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.

Authors:  Gert Van Assche; Axel Dignass; Bernd Bokemeyer; Silvio Danese; Paolo Gionchetti; Gabriele Moser; Laurent Beaugerie; Fernando Gomollón; Winfried Häuser; Klaus Herrlinger; Bas Oldenburg; Julian Panes; Francisco Portela; Gerhard Rogler; Jürgen Stein; Herbert Tilg; Simon Travis; James O Lindsay
Journal:  J Crohns Colitis       Date:  2012-10-03       Impact factor: 10.020

View more
  15 in total

Review 1.  Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Sawan Bopanna; Ashwin N Ananthakrishnan; Saurabh Kedia; Vijay Yajnik; Vineet Ahuja
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-02-21

2.  A low-cost method for chromoendoscopy for surveillance in ulcerative colitis.

Authors:  Sawan Bopanna; Saurabh Kedia; Vineet Ahuja
Journal:  Indian J Gastroenterol       Date:  2016-11-23

3.  Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.

Authors:  Islam Khan; Sue E Samson; Ashok Kumar Grover
Journal:  Med Princ Pract       Date:  2017-03-08       Impact factor: 1.927

4.  Long-term follow-up reveals high incidence of colorectal cancer in Indian patients with inflammatory bowel disease.

Authors:  Sawan Bopanna; Saurabh Kedia; Prasenjit Das; S Dattagupta; V Sreenivas; V Pratap Mouli; Rajan Dhingra; Rajesh Pradhan; N Suraj Kumar; Dawesh P Yadav; Govind Makharia; Vineet Ahuja
Journal:  United European Gastroenterol J       Date:  2016-11-17       Impact factor: 4.623

5.  Correlation of ulcerative colitis and colorectal cancer: a systematic review and meta-analysis.

Authors:  Yansong Wang; Pu Wang; Lixiang Shao
Journal:  J Gastrointest Oncol       Date:  2021-12

6.  Secondary colon cancer in patients with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Li Zhang; Huatian Gan
Journal:  J Gastrointest Oncol       Date:  2021-12

7.  Inflammatory bowel disease in India: challenges and opportunities.

Authors:  Alice Snell; Jonathan Segal; Jimmy Limdi; Rupa Banerjee
Journal:  Frontline Gastroenterol       Date:  2020-07-14

Review 8.  Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East.

Authors:  Saurabh Kedia; Vineet Ahuja
Journal:  Inflamm Intest Dis       Date:  2017-04-08

9.  Role of random biopsies in surveillance of dysplasia in ulcerative colitis patients with high risk of colorectal cancer.

Authors:  Sawan Bopanna; Maitreyee Roy; Prasenjit Das; S Dattagupta; V Sreenivas; V Pratap Mouli; Saurabh Kedia; Rajan Dhingra; Rajesh Pradhan; N Suraj Kumar; Dawesh P Yadav; Govind Makharia; Vineet Ahuja
Journal:  Intest Res       Date:  2016-06-27

10.  The effect of intermittent hypoxia and fecal microbiota of OSAS on genes associated with colorectal cancer.

Authors:  Jia Gao; Hailong Cao; Qiang Zhang; Bangmao Wang
Journal:  Sleep Breath       Date:  2020-10-07       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.